Etokimab (Antibody ANB 020) is a humanized monoclonal antibody that targets IL-33. Etokimab can be used for the research of atopic dermatitis[1].
IC 50
IL-3
References
[1] Chen YL, et, al. Proof-of-concept clinical trial of etokimab shows a key role for IL-33 in atopic dermatitis pathogenesis. Sci Transl Med. 2019 Oct 23;11(515):eaax2945. DOI:10.1126/scitranslmed.aax2945
